Vir Biotechnology and GSK Announce NHS-Supported AGILE Study to Evaluate VIR-7832 in the Early Treatment of COVID-19
Second monoclonal antibody from Vir-GSK collaboration to be investigated as a potential COVID-19 treatment
Preclinical data suggest VIR-7832 has two distinguishing properties: enhanced ability to clear infected cells and potential to enhance virus-specific T cell function, which could help treat and/or prevent COVID-19 infection
Trial targeted to begin in 1Q:2021 at multiple sites across the UK
SAN FRANCISCO and LONDON, Jan. 12, 2021 (GLOBE NEWSWIRE) Vir Biotechnology, Inc. (Nasdaq: VIR) and GlaxoSmithKline plc (LSE/NYSE: GSK) today announced an agreement with the U.K.-based AGILE initiative to evaluate VIR-7832 in patients with mild to moderate COVID-19 in a Phase 1b/2a clinical trial. VIR-7832 is a neutralizing COVID-19 antibody that preclinical data suggests has two distinguishing properties: an enhanced ability to clear infected cells and the potential to enh
Vir, GSK In Deal With NHS-Supported AGILE To Evaluate VIR-7832 In Early Treatment Of COVID-19
The trial is due to begin in the first quarter of 2021.
VIR-7832 is a neutralizing COVID-19 antibody that preclinical data suggests has two distinguishing properties. These are an enhanced ability to clear infected cells and the potential to enhance virus-specific T-cell function, which could help treat and/or prevent COVID-19 infection.
The AGILE trial platform will be the first to test VIR-7832 in humans. According to the companies, the AGILE trial platform uses adaptable protocols and statistical models to enable the evaluation of candidate medicines for COVID-19 treatment.
January 12, 2021
BEDFORDSHIRE, UK December 24, 2020 Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, is pleased to announce its professional-use COVID-19 Rapid Antigen Test has been certified with a CE mark, following independent assessment by the Liverpool School of Tropical Medicine (LSTM). The test will provide health professionals an accurate detection of the nucleoprotein of the SARS-CoV-2 virus in respiratory swabs, within 10 minutes. Development and validation were supported by the Wellcome Trust and the Foreign, Commonwealth and Development Office (FCDO) Joint Initiative on Research in Epidemic Preparedness and Response. The urgency for affordable diagnostics that are quality assured has been highlighted by the need to free people from quarantine and enable travel, commented professor Sanjeev Krishna, St George s University of London. Working within a consortium with Mologic and academic partners has been one of the most effective w
Dr David Weir, who was in his sixties, had worked for the NHS in North Manchester for 30 years, before moving to East Lancashire during the pandemic
A dedicated and respected respiratory doctor who went on the frontline to fight coronavirus has died from the illness.
Dr David Weir, who was in his sixties, had worked for the NHS in North Manchester for 30 years, before moving to East Lancashire during the pandemic.
He died from Covid-19 in December and is among 216 healthcare workers who have passed away from it.
East Lancashire Hospitals NHS Trust chief executive Kevin McGee led tributes to Dr Weir today.